IQCH
gene geneOn this page
Also known as FLJ12476
Summary
IQCH (IQ motif containing H, HGNC:25721) is a protein-coding gene on chromosome 15q23, encoding IQ domain-containing protein H (Q86VS3). May play a regulatory role in spermatogenesis.
Predicted to act upstream of or within lncRNA transcription and single fertilization. Predicted to be active in nuclear speck.
Source: NCBI Gene 64799 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 157 total
- MANE Select transcript:
NM_001031715
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25721 |
| Approved symbol | IQCH |
| Name | IQ motif containing H |
| Location | 15q23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ12476 |
| Ensembl gene | ENSG00000103599 |
| Ensembl biotype | protein_coding |
| OMIM | 612523 |
| Entrez | 64799 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 5 protein_coding, 4 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000335894, ENST00000512104, ENST00000514049, ENST00000535744, ENST00000558759, ENST00000559172, ENST00000559568, ENST00000560497, ENST00000560790, ENST00000561339, ENST00000561357, ENST00000629425
RefSeq mRNA: 11 — MANE Select: NM_001031715
NM_001031715, NM_001284347, NM_001284348, NM_001284349, NM_001322470, NM_001322471, NM_001322472, NM_001322473, NM_001322474, NM_001322475, NM_022784
CCDS: CCDS10223, CCDS32273, CCDS76772
Canonical transcript exons
ENST00000335894 — 21 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000942631 | 67395291 | 67395563 |
| ENSE00001108116 | 67490003 | 67490064 |
| ENSE00001198458 | 67254786 | 67254947 |
| ENSE00003491688 | 67416931 | 67417051 |
| ENSE00003514299 | 67465127 | 67465297 |
| ENSE00003519660 | 67400114 | 67400305 |
| ENSE00003532292 | 67359847 | 67359885 |
| ENSE00003535229 | 67373367 | 67373433 |
| ENSE00003536141 | 67261272 | 67261394 |
| ENSE00003542724 | 67475696 | 67475818 |
| ENSE00003549550 | 67494258 | 67494366 |
| ENSE00003556075 | 67357345 | 67357421 |
| ENSE00003582956 | 67500633 | 67501804 |
| ENSE00003583398 | 67384936 | 67385019 |
| ENSE00003591767 | 67372111 | 67372662 |
| ENSE00003593744 | 67344063 | 67344191 |
| ENSE00003597363 | 67263122 | 67263216 |
| ENSE00003640209 | 67336975 | 67337095 |
| ENSE00003640377 | 67279395 | 67279512 |
| ENSE00003665413 | 67388831 | 67389006 |
| ENSE00003681611 | 67421291 | 67421577 |
Expression profiles
Bgee: expression breadth ubiquitous, 181 present calls, max score 90.93.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 1.9204 / max 80.0551, expressed in 955 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 147343 | 1.0011 | 547 |
| 147342 | 0.8387 | 546 |
| 147346 | 0.0519 | 11 |
| 147344 | 0.0176 | 2 |
| 147345 | 0.0111 | 3 |
Top tissues by expression
284 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.93 | gold quality |
| buccal mucosa cell | CL:0002336 | 86.01 | gold quality |
| bronchial epithelial cell | CL:0002328 | 84.80 | gold quality |
| right uterine tube | UBERON:0001302 | 81.53 | gold quality |
| sperm | CL:0000019 | 80.38 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.42 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 79.17 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 79.01 | gold quality |
| male germ cell | CL:0000015 | 77.85 | silver quality |
| bronchus | UBERON:0002185 | 77.65 | gold quality |
| left testis | UBERON:0004533 | 77.63 | gold quality |
| testis | UBERON:0000473 | 77.39 | gold quality |
| right testis | UBERON:0004534 | 77.28 | gold quality |
| islet of Langerhans | UBERON:0000006 | 70.64 | gold quality |
| adenohypophysis | UBERON:0002196 | 69.43 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 68.64 | gold quality |
| thyroid gland | UBERON:0002046 | 68.64 | gold quality |
| pituitary gland | UBERON:0000007 | 68.40 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 68.26 | silver quality |
| calcaneal tendon | UBERON:0003701 | 68.00 | gold quality |
| adrenal tissue | UBERON:0018303 | 67.53 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 67.42 | gold quality |
| secondary oocyte | CL:0000655 | 66.98 | gold quality |
| stromal cell of endometrium | CL:0002255 | 66.95 | gold quality |
| oocyte | CL:0000023 | 66.47 | gold quality |
| metanephros cortex | UBERON:0010533 | 66.16 | gold quality |
| sural nerve | UBERON:0015488 | 66.01 | gold quality |
| fallopian tube | UBERON:0003889 | 65.63 | gold quality |
| tendon | UBERON:0000043 | 64.92 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 64.44 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.16 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
23 targeting IQCH, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-4697-3P | 99.89 | 67.09 | 1123 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-498-5P | 99.76 | 69.64 | 1807 |
| HSA-MIR-4677-5P | 99.70 | 70.09 | 1940 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-3978 | 99.24 | 68.39 | 2201 |
| HSA-MIR-6739-3P | 99.22 | 68.84 | 1843 |
| HSA-MIR-3908 | 98.75 | 67.31 | 1160 |
| HSA-MIR-3944-5P | 98.50 | 67.55 | 997 |
| HSA-MIR-1243 | 97.07 | 65.44 | 719 |
| HSA-MIR-582-3P | 96.69 | 67.38 | 1019 |
| HSA-MIR-376A-2-5P | 96.43 | 68.06 | 715 |
| HSA-MIR-217-3P | 95.67 | 68.42 | 1000 |
| HSA-MIR-6753-5P | 94.70 | 64.08 | 470 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | iqch | ENSDARG00000015476 |
| mus_musculus | Iqch | ENSMUSG00000037801 |
| rattus_norvegicus | Iqch | ENSRNOG00000008353 |
Protein
Protein identifiers
IQ domain-containing protein H — Q86VS3 (reviewed: Q86VS3)
Alternative names: Testis development protein NYD-SP5
All UniProt accessions (7): Q86VS3, B4E2J4, D6RGG0, H0YMU5, H3BMH8, H3BRL4, H3BU17
UniProt curated annotations — full annotation on UniProt →
Function. May play a regulatory role in spermatogenesis.
Tissue specificity. Expressed in fetal and adult testis, in germ cells but not somatic cells.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q86VS3-1 | 1 | yes |
| Q86VS3-2 | 2 | |
| Q86VS3-3 | 3 | |
| Q86VS3-4 | 4 | |
| Q86VS3-5 | 5 |
RefSeq proteins (11): NP_001026885, NP_001271276, NP_001271277, NP_001271278, NP_001309399, NP_001309400, NP_001309401, NP_001309402, NP_001309403, NP_001309404, NP_073621 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR038752 | IQCH | Family |
| IPR056855 | ATP-grasp_IQCH | Domain |
Pfam: PF24923
UniProt features (18 total): splice variant 11, region of interest 2, chain 1, domain 1, sequence variant 1, sequence conflict 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86VS3-F1 | 78.09 | 0.48 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 118 (showing top):
GOBP_SINGLE_FERTILIZATION, TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA, GOBP_FERTILIZATION, chr15q23, GOCC_NUCLEAR_SPECK, GOCC_NUCLEAR_BODY, GOCC_RIBONUCLEOPROTEIN_GRANULE, SCGGAAGY_ELK1_02, ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP, DODD_NASOPHARYNGEAL_CARCINOMA_DN, CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN, BRUINS_UVC_RESPONSE_LATE, GOCC_SUPRAMOLECULAR_COMPLEX, ASH1L_TARGET_GENES, CIITA_TARGET_GENES
GO Biological Process (4): single fertilization (GO:0007338), lncRNA transcription (GO:0140742), biological_process (GO:0008150), gene expression (GO:0010467)
GO Molecular Function (1): molecular_function (GO:0003674)
GO Cellular Component (2): nuclear speck (GO:0016607), cellular_component (GO:0005575)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| fertilization | 1 |
| DNA-templated transcription | 1 |
| macromolecule biosynthetic process | 1 |
| nuclear ribonucleoprotein granule | 1 |
Protein interactions and networks
STRING
416 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IQCH | LDHA | P00338 | 769 |
| IQCH | TESMIN | Q9Y4I5 | 447 |
| IQCH | SPATA16 | Q9BXB7 | 400 |
| IQCH | CATSPER1 | Q8NEC5 | 366 |
| IQCH | FEM1B | Q9UK73 | 351 |
| IQCH | TMTC1 | Q8IUR5 | 321 |
| IQCH | FER1L5 | A0AVI2 | 257 |
| IQCH | SLC25A31 | Q9H0C2 | 252 |
| IQCH | CATSPERD | Q86XM0 | 251 |
| IQCH | DMRT1 | Q9Y5R6 | 248 |
| IQCH | PKDREJ | Q9NTG1 | 247 |
| IQCH | SLC25A26 | Q70HW3 | 242 |
| IQCH | AASDH | Q4L235 | 240 |
| IQCH | PEG3 | P78418 | 228 |
| IQCH | CATSPERB | Q9H7T0 | 227 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| IQCH | COL6A2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| IQCH | MTHFD1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| NEK4 | E2F8 | psi-mi:“MI:0914”(association) | 0.350 |
| DDX3Y | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (8): CBX6 (Affinity Capture-MS), IQCH (Reconstituted Complex), IQCH (Synthetic Lethality), IQCH (Proximity Label-MS), IQCH (Proximity Label-MS), IQCH (Affinity Capture-MS), IQCH (Affinity Capture-RNA), APP (Reconstituted Complex)
ESM2 similar proteins: A0A1S4D1D3, A0A1W2PR95, A0A8I6ASZ5, A8WE67, D2K8N5, D3Z8X7, D3ZND0, E1C760, E7EXT2, F6Y9J3, F7AEX0, O08836, O60308, P27641, P54729, P78318, Q0P4W3, Q14CX7, Q15021, Q2QY04, Q2YD98, Q3ZC62, Q4V8E4, Q5EAU9, Q61249, Q68FJ0, Q6NY52, Q6PBQ2, Q6PGY6, Q6QI44, Q7ZXA8, Q80V31, Q86VS3, Q8BWZ3, Q8C6E0, Q8C9J3, Q8IYW2, Q8K2Z4, Q8LDQ4, Q8LNU5
Diamond homologs: Q1LXZ7, Q86VS3, Q9D2K4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
157 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 120 |
| Likely benign | 20 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
6786 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:67395319:T:C | L554P | 0.995 |
| 15:67395327:A:C | S557R | 0.995 |
| 15:67395329:T:A | S557R | 0.995 |
| 15:67395329:T:G | S557R | 0.995 |
| 15:67395420:G:C | A588P | 0.995 |
| 15:67400165:T:A | W653R | 0.994 |
| 15:67400165:T:C | W653R | 0.994 |
| 15:67372489:G:C | A378P | 0.993 |
| 15:67395421:C:A | A588D | 0.992 |
| 15:67373382:T:A | W441R | 0.991 |
| 15:67373382:T:C | W441R | 0.991 |
| 15:67373416:T:A | I452N | 0.991 |
| 15:67417018:T:A | W729R | 0.991 |
| 15:67417018:T:C | W729R | 0.991 |
| 15:67372655:G:C | R433P | 0.990 |
| 15:67385002:G:C | R480T | 0.990 |
| 15:67385003:G:C | R480S | 0.990 |
| 15:67385003:G:T | R480S | 0.990 |
| 15:67373408:G:C | R449S | 0.988 |
| 15:67373408:G:T | R449S | 0.988 |
| 15:67494308:T:C | L971P | 0.987 |
| 15:67372495:T:A | W380R | 0.986 |
| 15:67372495:T:C | W380R | 0.986 |
| 15:67372240:T:A | W295R | 0.985 |
| 15:67372240:T:C | W295R | 0.985 |
| 15:67372283:T:C | L309P | 0.985 |
| 15:67400207:G:C | A667P | 0.985 |
| 15:67421548:T:C | F826L | 0.985 |
| 15:67421550:T:A | F826L | 0.985 |
| 15:67421550:T:G | F826L | 0.985 |
dbSNP variants (sampled 300 via entrez): RS1000004452 (15:67342026 C>T), RS1000031142 (15:67436569 C>G,T), RS1000049406 (15:67291667 T>C), RS1000055887 (15:67485419 A>G), RS1000067544 (15:67337409 C>A), RS1000073173 (15:67264848 C>G), RS1000077292 (15:67388682 T>C), RS1000097606 (15:67382860 A>G), RS1000102937 (15:67500119 T>C), RS1000107719 (15:67446795 A>T), RS1000115106 (15:67482779 C>T), RS1000139503 (15:67432769 C>T), RS1000143118 (15:67289013 C>T), RS1000149785 (15:67343602 T>G), RS1000155936 (15:67298404 A>G)
Disease associations
OMIM: gene MIM:612523 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| propionaldehyde | increases expression | 1 |
| bisphenol A | affects expression | 1 |
| sodium arsenite | increases abundance, affects cotreatment, decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| manganese chloride | affects cotreatment, decreases expression, increases abundance | 1 |
| pentanal | decreases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| entinostat | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Leflunomide | increases expression | 1 |
| Arsenic | decreases expression, increases abundance, affects cotreatment | 1 |
| Manganese | affects cotreatment, decreases expression, increases abundance | 1 |
| N-Nitrosopyrrolidine | decreases expression | 1 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.